Abstract
The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.
| Original language | English |
|---|---|
| Pages (from-to) | 445 |
| Number of pages | 1 |
| Journal | Trends in Parasitology |
| Volume | 34 |
| Issue number | 5 |
| DOIs |
|
| State | Published - May 2018 |
All Science Journal Classification (ASJC) codes
- Parasitology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver